Test Directory
Targeted sequencing of ABL1 kinase domain exons 4 through 8 to identify point mutations associated with tyrosine kinase inhibitor (TKI) resistance in CML and Ph+ ALL. Guides selection of second- or third-generation TKI therapy.
Available as global and tech-only. Acute Lymphoblastic Leukemia (ALL) Panel nTdT, cMPO, cCD3, CD10, CD19, cCD22, CD34, CD45, cCD79a Comprehensive immunophenotyping panel for the diagnosis and lineage assignment of acute lymphoblastic leukemia. B-cell markers (CD19,
This panel is designed for the detection of genetic abnormalities commonly associated with acute myeloid leukemia (AML). It includes the following probes: CBFB inv(16), t(6;16) KMT2A (MLL) (11q23) PML/RARA t(15;17) RUNX1/RUNX1T1 (ETO/AML1) t(8;21) RPN1, MECOM
Available as global and tech-only. Acute Myeloid Leukemia (AML) Panel nTdT, cMPO, cCD3, CD11b, cCD22, CD34, CD45, cCD79a, CD117 Establishes myeloid lineage and blast immunophenotype in the workup of acute myeloid leukemia and undifferentiated acute
AFB III Staining Kit is intended for use as a qualitative histologic stain to selectively demonstrate Mycobacterium and other acid fast organisms or components in formalin-fixed, paraffin-embedded tissue.
Alcian Blue Staining Kit is intended for use as a qualitative histologic stain to demonstrate weakly acidic mucopolysaccharides. At pH 2.5, alcian blue stains sulfated and carboxylated acid mucopolysaccharides and sulfated and carboxylated sialomucins and
Alcian Yellow Staining Kit is intended for in vitro diagnostic (IVD) use as a qualitative histologic stain for Helicobacter pylori in formalin-fixed, paraffin embedded tissue.
Anti-p504s (SP116) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the detection of α-methylacyl-CoA racemase (AMACR) in sections of formalin-fixed, paraffin-embedded tissue.
Evaluates recurrent somatic mutations in IDH1, IDH2, KIT, CEBP-A, FLT3, and NPM1 relevant to acute myeloid leukemia classification, risk stratification, and targeted therapy eligibility (IDH1/2 inhibitors, FLT3 inhibitors).
The CLL FISH panel is used for the detection of chromosome aberrations observed in chronic lymphocytic leukemia/small lymphocytic lymphoma, which are useful in prognosis and prediction of time to treatment in CLL patients when used